JamiMillerMD
Dermatology • Nashville, TNAssistant Professor, Medicine, Vanderbilt University School of Medicine
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
719 Thompson Ln
Ste 26300
Nashville, TN 37204Phone+1 615-322-0845Fax+1 615-343-2591
Education & Training
Vanderbilt University Medical CenterResidency, Dermatology, 1991 - 1994- Vanderbilt University Medical CenterResidency, Internal Medicine, 1988 - 1991
University of Virginia School of MedicineClass of 1988
Certifications & Licensure
VA State Medical License 2005 - 2026
TN State Medical License 1994 - 2025
CA State Medical License 2005 - 2023
AL State Medical License 2020 - 2020- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study Start of enrollment: 2019 May 02
Publications & Presentations
PubMed
- 21 citationsIllicit drugs: What dermatologists need to knowCara Hennings, Jami L. Miller
Journal of the American Academy of Dermatology. 2013-07-01 - 12 citationsUnilateral facial angiofibromas without other evidence of tuberous sclerosis: case report and review of the literature.Matthew R Hall, Bradley T Kovach, Jami L. Miller
Cutis. 2007-10-01 - 14 citationsFamilial ulcerative pyoderma gangrenosum: a report of 2 kindred.Jennifer H. Alberts, Hunter H. Sams, Jami L. Miller, Lloyd E. King
Cutis. 2002-06-01
Authored Content
- 50 Pearls in 50 Minutes: Take Home Points for DermatologistsNovember 2020
- 3 Big Takeaways from Fall Clinical Dermatology: STDs, LGV, and ScabiesNovember 2020
Press Mentions
Abrocitinib Evaluated in Patients with and Without Prior Dupilumab TreatmentAugust 23rd, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
